Dr. Chen received his M.D. in medicine from the Capital Medical University, Beijing, China, in 2011. He completed his doctoral training in the Department of Orthopaedic at Beijing Chao-Yang Hospital (in 2016, China). From 2013 to 2016, Dr. Chen worked at the Beijing Chao-Yang Hospital as a Spine Surgeon. In 2018, he joined Spine Labs of UNSW for doctoral training. Dr Chen has been awarded many international grants, including The International Society for the Study of the Lumbar Spine (ISSLS) traveling fellowship award (clinical fellow at Spine Service, UNSW, Australia), AOSpine clinical research award, NASS traveling fellowship award (fellow at Keck Hospital, USC, USA), International ISSLS Young Investigator Travel Grant, etc. Dr Chen’s previous work focused on the studies on big data and databases, biomechanical and biological changes, and clinical related research in degenerative spine diseases.
2019 – 2020: AOSpine Australasia Research Grand, CHF 5,000
2019 International ISSLS Young Investigator Travel Grant, US$ 1,000
2018 – 2018: ISSLS travelling fellowship, US$ 5,000
2016 – 2017: AOSpine China Research Grand, CHF 5,000
2015 – 2016: NASS travelling fellowship, US$ 5,000
National Natural Science Foundation of China (2017 – 2020: RMB 100,000; 2015 –2018: RMB 100,000; 2009 – 2011: RMB 50,000)
Beijing Municipal Science and Technology Project (2013: RMB 50,000; 2010: RMB 50,000)
series of studies (e.g., ) investigating a hierarchy of complication rates following different discectomy techniques, and then explores factors like surgical technique variations, altered tissue molecular markers, and disc height measurements in the context of discectomy. The findings revealed that a plethora of techniques used for measuring disc height index were never subjected to the proper evaluation.
Based on his PhD study, Dr. Chen and his team developed a novel nucleus replacement device (https://www.kunovus.com) for treating the patients with lumbar disc herniation. His ability to evaluate an elastomeric disc spacer biomechanically and to conduct an early clinical trial was curtailed due to the pandemic during the PhD period. However, he is pursuing that as his post-doctoral work at Kunovus Technologies for the biomechanical and biocompatibility testing and clinical trial of the novel nucleus device.
Dr. Chen collaborates some international research institutions for many projects.